Physician profile
Peter R Young
NPI 1417971532
$4,474.82
in general payments reported to CMS, 2019-2025
11 companies · $4,192 in 2025
The $4,192 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $14.08 · 2021: $92.28 · 2022: $28.54 · 2025: $4,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,710 · Travel and Lodging: $1,060 · Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,710.15 |
| Travel and Lodging | $1,059.87 |
| Food and Beverage | $421.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,023.79 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $160.14 | 2025 | Keytruda, Lynparza |
| Allergan, INC. | $47.28 | 2019 | |
| Coloplast Corp | $46.03 | 2025 | |
| Smith+Nephew, INC. | $41.64 | 2025 | Pico 7, Renasys Touch |
| Davol INC. | $39.17 | 2021 | |
| Kci USA, INC. | $35.36 | 2019-2020 | |
| Ethicon US, LLC | $22.88 | 2019 | |
| W. L. Gore & Associates, INC. | $21.35 | 2021 | |
| Conmed Corporation | $20.93 | 2025 | Airseal |
| Focal Therapeutics, INC. | $16.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.